1. Home
  2. TVTX vs SAFT Comparison

TVTX vs SAFT Comparison

Compare TVTX & SAFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVTX
  • SAFT
  • Stock Information
  • Founded
  • TVTX 2008
  • SAFT 1979
  • Country
  • TVTX United States
  • SAFT United States
  • Employees
  • TVTX N/A
  • SAFT N/A
  • Industry
  • TVTX Biotechnology: Pharmaceutical Preparations
  • SAFT Property-Casualty Insurers
  • Sector
  • TVTX Health Care
  • SAFT Finance
  • Exchange
  • TVTX Nasdaq
  • SAFT Nasdaq
  • Market Cap
  • TVTX 1.3B
  • SAFT 1.1B
  • IPO Year
  • TVTX N/A
  • SAFT N/A
  • Fundamental
  • Price
  • TVTX $14.92
  • SAFT $76.86
  • Analyst Decision
  • TVTX Strong Buy
  • SAFT
  • Analyst Count
  • TVTX 13
  • SAFT 0
  • Target Price
  • TVTX $33.75
  • SAFT N/A
  • AVG Volume (30 Days)
  • TVTX 2.0M
  • SAFT 75.7K
  • Earning Date
  • TVTX 05-05-2025
  • SAFT 05-07-2025
  • Dividend Yield
  • TVTX N/A
  • SAFT 4.69%
  • EPS Growth
  • TVTX N/A
  • SAFT 273.44
  • EPS
  • TVTX N/A
  • SAFT 4.78
  • Revenue
  • TVTX $233,175,000.00
  • SAFT $1,120,017,000.00
  • Revenue This Year
  • TVTX $68.31
  • SAFT N/A
  • Revenue Next Year
  • TVTX $55.65
  • SAFT N/A
  • P/E Ratio
  • TVTX N/A
  • SAFT $16.08
  • Revenue Growth
  • TVTX 60.55
  • SAFT 20.31
  • 52 Week Low
  • TVTX $5.12
  • SAFT $70.71
  • 52 Week High
  • TVTX $25.29
  • SAFT $90.00
  • Technical
  • Relative Strength Index (RSI)
  • TVTX 37.07
  • SAFT 48.46
  • Support Level
  • TVTX $14.13
  • SAFT $73.77
  • Resistance Level
  • TVTX $15.23
  • SAFT $80.02
  • Average True Range (ATR)
  • TVTX 1.31
  • SAFT 2.71
  • MACD
  • TVTX -0.10
  • SAFT -0.01
  • Stochastic Oscillator
  • TVTX 31.70
  • SAFT 59.82

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

About SAFT Safety Insurance Group Inc.

Safety Insurance Group Inc is a provider of private passenger automobile insurance in Massachusetts. The company also offers property and casualty insurance products, including commercial automobiles, homeowners, dwelling fire, umbrella, and business owner policies. It operates in the business segment of Property and casualty insurance operations.

Share on Social Networks: